Yahoo Finance

Organicell Regenerative Medicine, Inc. Closes $5.5 Million Funding Round

MIAMI, FL / ACCESSWIRE / August 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focused on the development of innovative ...
Yahoo Finance

Organicell Starts Enrolling Long COVID Trial

MIAMI, FL / ACCESSWIRE / November 17, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB: OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological ...
Business Wire

Organicell Announces FDA Approval of IND Application for the Use of Zofin™ in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

MIAMI--(BUSINESS WIRE)--Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that ...
The Globe and Mail

Organicell Regenerative Medicine, Inc. Responds to Recent Promotional Activities Pursuant to OTC Markets Request

DAVIE, FL / ACCESSWIRE / November 21, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) ("Organicell" or the "Company") has been requested by OTC Markets Group, Inc. ("OTC Markets") to issue ...
Business Wire

Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19

MIAMI--(BUSINESS WIRE)--Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced its ...
newswire

Organicell Announces Matt Sinnreich as CEO

MIAMI, FL, July 26, 2022 (Newswire.com) - Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focusing on the development of innovative ...
Nasdaq

Organicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting

MIAMI--(BUSINESS WIRE)-- Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that ...
newswire

Organicell Reports Interim Results of Phase 1/2A Research Program

FORT LAUDERDALE, FL, July 26, 2023 (Newswire.com) - . (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, today ...
Nasdaq

Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19

MIAMI, May 05, 2020 (GLOBE NEWSWIRE) -- Organicell Regenerative Medicine, Inc. (OTCBB:BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, ...
Finanznachrichten

Organicell Regenerative Medicine, Inc. And Proxima CRO Set To Open Clinical Trial For Long Hauler COVID-19 Patients

MIAMI, FL / ACCESSWIRE / February 8, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, ...